stockrowSotera Health Company
SHC Healthcare Diagnostics & Research
Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024.
- Revenue
- +4.36%
- EPS
- +20.1%
- Free cash flow
- +65.0%
- Total debt
- +0.14%
Quarter to September 2026, against a year earlier
Follow SHC
Alert me
Sotera Health Company (SHC) Operating cash flow
Sotera Health Company's operating cash flow for fiscal 2025 was $287.2M, up 28.1% from $224.2M in fiscal 2024. Over the twelve months to 30 September 2026 it was $331.6M. Over the past ten years it has ranged from −$147.7M (fiscal 2023) to $287.2M (fiscal 2025) — the current reading is the highest in ten years. Sotera Health Company ranks 16th of 49 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $287.2M | 28.12% |
| FY2024 | $224.2M | — |
| FY2023 | −$147.7M | — |
| FY2022 | $278.0M | (1.27%) |
| FY2021 | $281.5M | 133.48% |
| FY2020 | $120.6M | (19.09%) |
| FY2019 | $149.0M | 24.65% |
| FY2018 | $119.6M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $110.5M | 24.92% |
| Jun 2026 | $88.5M | 200.65% |
| Mar 2026 | $29.4M | (71.45%) |
| Dec 2025 | $103.1M | 44.90% |
| 25 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| QGEN QIAGEN N.V. compare | $654.5M |
| SHC Sotera Health Company | $331.6M |
| RDNT RadNet, Inc. compare | $310.1M |
| VCYT Veracyte, Inc. compare | $173.9M |
| CDNA CareDx, Inc. compare | $69.0M |
| BLLN BillionToOne, Inc. compare | $47.9M |
| NEO NeoGenomics, Inc. compare | $4.3M |
| ADPT Adaptive Biotechnologies Corporation compare | −$4.3M |
| GRAL GRAIL, Inc. compare | −$306.2M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on SHC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement